May 13 (Reuters)-
OncoTherapy Science Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2016 Mar 31, 2015 Mar 31, 2017 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 266 mln 569 mln
(-53.2 pct) (-34.3 pct)
Operating loss 2.92 loss 2.12
Recurring loss 2.90 loss 2.12
Net loss 2.78 loss 1.83
EPS loss 18.90 yen loss 12.44 yen
Ann Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - OncoTherapy Science Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T
((Tokyo Headline News Desk +813 6441 1812))